(FJAN) First Trust Exchange-Traded - Ratings and Ratios
Exchange: BATS • Country: USA • Currency: USD • Type: Etf • ISIN: US33740F6236
FJAN: Options, Equity Linked Securities
The First Trust Exchange-Traded Fund VIII - FT Cboe Vest U.S. Equity Buffer ETF - January (BATS:FJAN) is an exchange-traded fund that employs a unique investment strategy to achieve its objectives. Under normal market conditions, the fund invests substantially all of its assets in FLexible EXchange Options (FLEX Options) that reference the price performance of the SPDR S&P 500 ETF Trust. This approach allows the fund to benefit from the performance of the underlying ETF while providing a level of protection against potential losses.
FLEX Options are customized equity or index option contracts that trade on an exchange, offering investors the flexibility to tailor key contract terms such as exercise prices, styles, and expiration dates. By utilizing FLEX Options, the fund can create a defined outcome strategy that seeks to provide a buffer against potential losses in the underlying ETF. This strategy is particularly appealing to investors seeking to manage risk in their portfolios.
As a non-diversified fund, FJANs investment strategy is focused on a specific asset class, which in this case is the SPDR S&P 500 ETF Trust. The funds assets under management (AUM) currently stand at $1.043 billion, indicating a significant level of investor interest in this particular strategy.
Analyzing the technical data, we can observe that the funds last price is $46.65, which is above its 20-day simple moving average (SMA) of $46.21 and 50-day SMA of $44.70. The 200-day SMA is $45.16, indicating a longer-term uptrend. The average true range (ATR) is 0.36, representing a daily price movement of 0.78%. Given the current trend and volatility, we can forecast that FJAN is likely to continue its upward trajectory, potentially reaching the 52-week high of $46.83 in the near term.
Combining the technical and fundamental analysis, our forecast suggests that FJAN is poised for further growth, driven by its defined outcome strategy and the overall performance of the underlying ETF. With its AUM continuing to grow, the fund is likely to remain an attractive option for investors seeking to balance risk and potential returns in their portfolios.
Additional Sources for FJAN ETF
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
FJAN ETF Overview
Market Cap in USD | 1,062m |
Category | Defined Outcome |
TER | 0.85% |
IPO / Inception | 2021-01-15 |
FJAN ETF Ratings
Growth Rating | 67.9 |
Fundamental | - |
Dividend Rating | 0.0 |
Rel. Strength | -4.57 |
Analysts | - |
Fair Price Momentum | 45.48 USD |
Fair Price DCF | - |
FJAN Dividends
Currently no dividends paidFJAN Growth Ratios
Growth Correlation 3m | 92.6% |
Growth Correlation 12m | 51.4% |
Growth Correlation 5y | 90.9% |
CAGR 5y | 10.67% |
CAGR/Max DD 5y | 0.79 |
Sharpe Ratio 12m | 0.97 |
Alpha | -0.40 |
Beta | 0.535 |
Volatility | 7.56% |
Current Volume | 25k |
Average Volume 20d | 19.9k |
As of July 01, 2025, the stock is trading at USD 47.55 with a total of 24,991 shares traded.
Over the past week, the price has changed by +1.91%, over one month by +3.04%, over three months by +7.22% and over the past year by +9.46%.
Yes. Based on ValueRay´s Analyses, First Trust Exchange-Traded (BATS:FJAN) is currently (July 2025) a good stock to buy. It has a ValueRay Growth Rating of 67.87 and therefor a clear technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of FJAN is around 45.48 USD . This means that FJAN is currently overvalued and has a potential downside of -4.35%.
First Trust Exchange-Traded has no consensus analysts rating.
According to our own proprietary Forecast Model, FJAN First Trust Exchange-Traded will be worth about 51.3 in July 2026. The stock is currently trading at 47.55. This means that the stock has a potential upside of +7.84%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 51.3 | 7.8% |